Advertisement

In Vitro Predictive Sensitivity Testing in the Therapeutic Assessment of Breast Cancer

  • J. T. Emerman

Abstract

The choice of endocrine therapy and chemotherapy used in the treatment of breast cancer is largely empirically derived, based on data obtained from clinical trials [32]. However, patients with the same tumor pathology may not respond to the same cytotoxic drugs. Steroid hormone receptors, used to predict hormone responsiveness of breast tumors, greatly improve the probability of response, but does not ensure that a patient will benefit from endocrine manipulations. Inappropriate treatments result in valuable time lost for alternative therapy and unnecessary suffering from side effects of antineoplastic agents. A major aspect of breast cancer biology responsible for therapeutic failures is tumor heterogeneity; tumors contain varying numbers of hormone- and drug-responsive and hormone- and drug-resistant cells [47].

Keywords

Clonogenic Assay Human Mammary Epithelial Cell Chemosensitivity Testing Therapeutic Assessment Human Mammary Tumor Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alberts DS, Salmon SE, Chen HSG, Moon TE, Young L, Surwit EA (1981) Pharmacologic studies of anticancer drugs with the human tumor stem cell assay. Cancer Chemother Pharmacol 6:253–264PubMedGoogle Scholar
  2. 2.
    Albrecht M, Simon WE, Hölzel F (1985) Individual chemosensitivity of in vitro proliferating mammary and ovarian carcinoma cells in comparison to clinical results of chemotherapy. J Cancer Res Clin Oncol 109: 210–216PubMedGoogle Scholar
  3. 3.
    Alley MC, Powis G, Appel PL, Kooistra KL, Lieber MM (1984) Activation and inactivation of cancer chemotherapeutic agents by rat hepatocytes cocultured with human tumor cell lines. Cancer Res 44: 549–556PubMedGoogle Scholar
  4. 4.
    Barnes D, Sato G (1980) Methods for growth of cultured cells in serum-free medium. Anal Biochem 102: 255–270PubMedGoogle Scholar
  5. 5.
    Benz C, Cadman E, Gwin J, Terrence W, Amara J, Eisenfeld A, Dannies P (1983) Tamoxifen and 5-fluorouracil in breast cancer: cytotoxic synergism in vitro. Cancer Res 43: 5298–5303PubMedGoogle Scholar
  6. 6.
    Berry RJ, Laing AH, Wills J (1975) Fresh explant culture of human tumours in vitro and the assessment of sensitivity to cytotoxic chemotherapy. Br J Cancer 31:218–227PubMedGoogle Scholar
  7. 7.
    Bertelsen CA, Sondak VK, Mann BD, Korn EL, Kern DH (1984) Chemosensitivity testing of human solid tumors: a review of 1582 assays with 258 clinical correlations. Cancer 53: 1240–1245PubMedGoogle Scholar
  8. 8.
    Bickis IJ, Henderson IWD, Quaster JH (1966) Biochemical studies of human tumors. II. In vitro estimation of individual tumor sensitivity to anticancer agents Cancer 19· 103–113PubMedGoogle Scholar
  9. 9.
    Brereton HD, Bryant TL, Young RC (1975) Inhibition and recovery of DNA synthesis in host tissues and sensitive and resistant B16 melanoma after l–2(2-chloroethyl)-3- (trans-4-methylcyclohexyl)-1 -nitrosourea, a predictor of therapeutic efficacy. Cancer Res 35: 2420–2425PubMedGoogle Scholar
  10. 10.
    Carlsson J, Yuhas JM (1984) Liquid-overlay culture of cellular spheroids. In: Acker H, Carlsson J, Durand R, Sutherland R (eds) Spheroids in cancer research. Springer, Berlin Heidelberg New York, pp 1–23 (Recent results in cancer research, vol. 95)Google Scholar
  11. 11.
    Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936–942PubMedGoogle Scholar
  12. 12.
    Cillo C, Odartchenko N (1984) Cloning of human tumor cells in methylcellulose- containing medium. Hofmann V, Berens ME, Martz G (eds) Predictive drug testing on human tumor cells. Springer, Berlin Heidelbrg New York, pp 56–64 (Recent results in cancer research, vol. 94)Google Scholar
  13. 13.
    Clarke R, Van den Berg HW, Kennedy DG, Murphy RF (1985) Oestrogen receptor status and the response of human breast cancer cell lines to a combination of methotrexate and 17-β-oestradiol. Br J Cancer 51: 365–369PubMedGoogle Scholar
  14. 14.
    Conte PF, Fraschini G, Alama A, Nicolin A, Corsaro E, Conavese G, Rosso R, Drewinko B (1985) Chemotherapy following estrogen-induced expansion of the growth fraction of human breast cancer. Cancer Res 45: 5926–5930PubMedGoogle Scholar
  15. 15.
    Courtenay VD, Mills J (1978) In vitro colony assay for human tumours grown in immunesuppressed mice and treated in vivo with cytotoxic agents. Br J Cancer 37: 261–268PubMedGoogle Scholar
  16. 16.
    Daidone MG, Silvestrini R, Sanfilippo O, Zaffaroni N, Varini M, De Lena M (1985) Reliability of an in vitro short-term assay to predict the drug sensitivity of human breast cancer. Cancer 56: 450–456PubMedGoogle Scholar
  17. 17.
    Darling JL, Thomas DGT (1983) Results obtained using assays of intermediate duration and clinical correlations. In: Dendy PP, Hill BT (eds) Human tumour drug sensitivity testing in vitro. Academic, London, pp 269–280Google Scholar
  18. 18.
    Das NK, Hosick HL, Nandi S (1974) Influences of seeding density on multicellular organization and nuclear events in cultures of normal and neoplastic mouse mammary epithelium. J N C I 52: 849–861Google Scholar
  19. 19.
    Dedrick RL, Myers CE, Bungay PM, De Vita VT Jr (1978) Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer Cancer Treat Rep 62: 1–11PubMedGoogle Scholar
  20. 20.
    Dendy PP, Bozman G, Wheeler TK (1970) In vitro screening test for human malignant tumours before chemotherapy. Lancet ii: 68Google Scholar
  21. 21.
    Dendy PP, Hill BT (eds) (1983) Human tumour drug sensitivity testing in vitro. Academic, LondonGoogle Scholar
  22. 22.
    Di Paolo JA, Dowd JE (1961) Evaluation of inhibition of human tumour tissue by cancer chemotherapeutic drugs with an in vitro test. J N C I 27: 807–815Google Scholar
  23. 23.
    Dittrich C, Jakesz R, Wrba F, Havelec L, Haas O, Spona J, Holzner H, Kolb R, Moser K (1985) The human tumour cloning assay in the management of breast cancer patients. Br J Cancer 52: 197–203PubMedGoogle Scholar
  24. 24.
    Drewinko B, Patchen M, Yang L-Y, Barlogie B (1981) Differential killing efficacy of twenty antitumor drugs on proliferating and nonproliferating human tumor cells Cancer Res 41: 2328–2333PubMedGoogle Scholar
  25. 25.
    Emerman JT, Bartley JC, Bissel MJ (1981) Glucose metabolite patterns as markers of functional differentiation in freshly isolated and cultured mouse mammary epithelial cells. Exp Cell Res 134: 241–250PubMedGoogle Scholar
  26. 26.
    Emerman JT, Enami J, Pitelka DR, Nandi S (1977) Hormonal effects on intracellular and secreted casein in cultures of mouse mammary epithelial cells on floating collagen membranes. Proc Natl Acad Sci USA 74: 4466–4470PubMedGoogle Scholar
  27. 27.
    Emerman JT, Fiedler EE, Tolcher AW, Rebbeck PM (1987) Effects of defined medium, fetal bovine serum, and human serum on growth and chemosensitivities of human breast cancer cells in primary culture: inference for in vitro assays. In Vitro Cell Dev Biol 23: 134–140PubMedGoogle Scholar
  28. 28.
    Emerman JT, Pitelka DR (1977) Maintenance and induction of morphological differentiation in dissociated mammary epithelium on floating collagen membranes. In Vitro 13: 316–328PubMedGoogle Scholar
  29. 29.
    Emerman JT, Siemiatkowski J (1984) Effects of endocrine regulation of growth of a mouse mammary tumor on its sensitivity to chemotherapy. Cancer Res 44: 1327–1332PubMedGoogle Scholar
  30. 30.
    Emerman JT, Worth AJ (1985) Phenotypic stability of mouse mammary tumor cells cultured on collagen gels. In Vitro Cell Dev Biol 21: 49–56PubMedGoogle Scholar
  31. 31.
    Fan D, Schneider C, Fan S, Blank H, Gillen L, Morgan LR (1984) Effects of estrogen, tamoxifen and progesterone on a human breast cancer line in the soft-agar assay. In: Salmon SE, Trent JM (eds) Human tumor cloning. Grune and Stratton, Orlando, pp 477–486Google Scholar
  32. 32.
    Forrest APM (1986) Advances in management of carcinoma of breast. Surg Gynecol Obstet 163: 89–100PubMedGoogle Scholar
  33. 33.
    Freshney RI, Dendy PP (1983) Culture methods for assays of intermediate duration. In: Dendy PP, Hill BT (eds) Human tumour drug sensitivity testing in vitro. Academic, London, pp 69–89Google Scholar
  34. 34.
    Freshney RI, Paul J, Kane IM (1975) Assay of anticancer drugs in tissue culture: conditions affecting their ability to incorporate 3H-leucine after drug treatment. Br J Cancer 31: 89–99PubMedGoogle Scholar
  35. 35.
    Friedman HM, Glaubiger DL (1982) Assessment of in vitro drug sensitivity of human tumor cells using [3H] thymidine incorporation in a modified human tumor stem cell assay. Cancer Res 42: 4683–4689PubMedGoogle Scholar
  36. 36.
    Gaffney EV, Pigott D (1978) Hydrocortisone stimulation of human mammary epithelial cells. In Vitro 14: 621–624PubMedGoogle Scholar
  37. 37.
    Goldenberg GJ, Froese EK (1982) Drug and hormone sensitivity of estrogen receptor- positive and negative human breast cancer cells in vitro. Cancer Res 42: 5147–5151PubMedGoogle Scholar
  38. 38.
    Goldenberg GJ, Froese EK (1985) Antagonism of the cytocidal activity and uptake of melphalan by tamoxifen in human breast cancer cells in vitro. Biochem Pharmacol 34: 763–770PubMedGoogle Scholar
  39. 39.
    Group for Sensitivity Testing of Human Tumours (KSST) (1981) In vitro short-term test to determine the resistance of human tumours to chemotherapy. Cancer 48: 2127–2135Google Scholar
  40. 40.
    Gupta V, Costanzi JJ (1987) Role of hypoxia in anticancer drug-induced cytotoxicity for Ehrlich ascites cells. Cancer Res 47: 2407–2412PubMedGoogle Scholar
  41. 41.
    Haeuptle M, Suard YLM, Bogenmann E (1983) Effect of cell shape change on the function and differentiation of rabbit mammary cells in culture. J Cell Biol 96: 1425–1434PubMedGoogle Scholar
  42. 42.
    Haji-karim M, Carlsson J (1978) Proliferation and viability in cellular spheroids of human origin. Cancer Res 38: 1457–1464PubMedGoogle Scholar
  43. 43.
    Hamburger AW, Salmon SE (1977) Primary bioassay of human tumor stem cells. Science 197: 461–463PubMedGoogle Scholar
  44. 44.
    Hammond SL, Ham RG, Stampfer MR (1984) Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc Natl Acad Sci USA 81: 5435–5439PubMedGoogle Scholar
  45. 45.
    Hanson JA, Bean EA, Coombs AM, Moore JL (1985) A comparison of two in vitro assays of cell response following in vitro drug and radiation exposures of human tumour xenograft cells. Br J Cancer 52: 637–640PubMedGoogle Scholar
  46. 46.
    Haslam SZ (1986) Mammary fibroblast influence on normal mouse mammary epithelial cell responses to estrogen in vitro. Cancer Res 46: 310–316PubMedGoogle Scholar
  47. 47.
    Heppner GH, Miller B, Cooper DN, Miller FR (1981) Growth interactions between mammary tumor cells. In: Brenner NJ, McGrath CM (eds) Cell biology of breast cancer. Academic, New York, pp 161–172Google Scholar
  48. 48.
    Hill BT, Whelan RDH, Rupniak HT, Dennis LY, Rosholt MA (1981) A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfluorimetry. Cancer Chemother Pharmacol 7: 21–26PubMedGoogle Scholar
  49. 49.
    Holmes HL, Little JM (1974) Tissue-culture microtest for predicting response of human cancer to chemotherapy. Lancet ii: 985–987Google Scholar
  50. 50.
    Hölzel F, Albrecht M, Simon WE, Hänsel M, Metz R, Schweizer J, Dietel M (1985) Effectiveness of antineoplastic drugs on the proliferation of human mammary and ovarian carcinoma cells in monolayer culture. J Cancer Res Clin Oncol 109: 217–226PubMedGoogle Scholar
  51. 51.
    Houghton PJ, Taylor DN (1977) Fractional incorporation of [3H] thymidine and DNA specific activity as assays of inhibition of tumour growth. Br J Cancer 35: 68–77PubMedGoogle Scholar
  52. 52.
    Hug V, Haynes M, Rashid R, Spitzer G, Blumenschen G, Hortobagyi G (1984) Improved culture conditons for clonogenic growth of primary human breast tumours. Br J Cancer 50: 207–213PubMedGoogle Scholar
  53. 53.
    Hug V, Hortobagyi G, Drewinko B, Finders M (1985) Tamoxifen-citrate counter-acts the antitumor effects of cytotoxic drugs in vitro. J Clin Oncol 3: 1672–1677PubMedGoogle Scholar
  54. 54.
    Hug V, Johnston D, Finders M, Hortobagyi G (1986) Use of growth-stimulating hormones to improve the in vitro therapeutic index of doxorubicin for human breast tumors. Cancer Res 46: 147–152PubMedGoogle Scholar
  55. 55.
    Hug V, Thames H, Hortobagyi G, Finders M (1986) Chemosensitivities of human clonogenic breast tumour cells. Eur J Cancer Clin Oncol 22: 971–981PubMedGoogle Scholar
  56. 56.
    Ikeda T, Liu Q, Danielpour D, Officer JB, Iio M, Leland FE, Sirbasku DA (1982) Identification of estrogen-inducible growth factors (estromedins) for rat and human mammary tumor cells in culture. In Vitro 18: 961–979PubMedGoogle Scholar
  57. 57.
    Jones CA, Tsukamoto T, O’Brien PC, Uhl CB, Alley MC (1985) Soft agarose culture human tumour colony forming assay for drug sensitivity testing: [3H]-thymidine incorporation vs colony counting. Br J Cancer 52: 303–310PubMedGoogle Scholar
  58. 58.
    Jozan S, Gay G, Marques B, Mirouze A, David JF (1985) Oestradiol is effective in stimulating 3H-thymidine incorporation, but not on proliferation of breast cancer cultured cells. Cell Tissue Kinet 18: 457–464PubMedGoogle Scholar
  59. 59.
    Kaltenbach JP, Kaltenbach ΜΗ, Lyons WB (1958) Nigrosin as a dye for differentiating live and dead ascites cells. Exp Cell Res 15: 112–117PubMedGoogle Scholar
  60. 60.
    Kennedy DG, Van den Berg HW, Clarke R, Murphy RF (1986) Enhancement of methotrexate cytotoxicity towards the MDA. MB. 436 human breast cancer cell line by dipyridamole. Biochem Pharmacol 35: 3053–3056PubMedGoogle Scholar
  61. 61.
    Kern DH, Drogemuller CR, Kennedy MC, Hildebrand-Zanki SU, Tanigawa N, Sondak VK (1985) Development of a miniaturized, improved nucleic acid precursor incorporation assay for chemosensitivity testing of human solid tumors. Cancer Res 45: 5436–5441PubMedGoogle Scholar
  62. 62.
    Klevjer-Anderson P, Buehring GC (1980) Effect of hormones on growth rates of malignant and nonmalignant human mammary epithelia in culture. In Vitro 16: 491– 501PubMedGoogle Scholar
  63. 63.
    Kornblith PL, Smith BH, Leonard LA (1981) Response of cultured human brain tumours to nitrosoureas: correlation with clinical data. Cancer 47: 255–261PubMedGoogle Scholar
  64. 64.
    Kwok TT, Twentyman PR (1985) The response to cytotoxic drugs of EMTG cells treated either as intact or disaggregated spheroids. Br J Cancer 51: 211–218PubMedGoogle Scholar
  65. 65.
    Laboisse CL, Augeron C, Potet F (1981) Growth and differentiation of human gastrointestinal adenocarcinoma stem cells in soft agarose. Cancer Res 41: 310–315PubMedGoogle Scholar
  66. 66.
    Lawler EM, Miller FR, Heppner GH (1983) Significance of three-dimensional growth patterns of mammary tissues in collagen gels. In Vitro 19: 600–610PubMedGoogle Scholar
  67. 67.
    Leclercq G, Devleeschouwer N, Danguy A, Verrijdt A, Heuson JC (1985) In vitro synergism between estrogens and cytotoxic agents. J Steroid Biochem 23: 1111–1113PubMedGoogle Scholar
  68. 68.
    Lee EYH, Lee WH, Kaetzel CS, Parry G, Bissell MJ (1985) Interaction of mouse mammary epithelial cells with collagenous substrata: regulation of casein gene expression and secretion. Proc Natl Acad Sci USA 82: 1419–1423PubMedGoogle Scholar
  69. 69.
    Lickiss JN, Cane KA, Baikie AG (1974) In vitro drug selection in antineoplastic chemotherapy. Eur J Cancer 10: 809–814PubMedGoogle Scholar
  70. 70.
    Limburg H, Heckmann C (1968) Chemotherapy in the treatment of advanced pelvic malignant disease with special reference to ovarian cancer. J Obstet Gynaecol 75:1246– 1250Google Scholar
  71. 71.
    Lippman ME, Cassidy J, Wesley M, Young RC (1985) Increasing the response rate to cytotoxic chemotherapy by endocrine means. J Steroid Biochem 23: 1173–1180PubMedGoogle Scholar
  72. 72.
    Livingstone RB, Titus GA, Heilbrun LK (1980) In vitro effects on DNA synthesis as a predictor of biological effect from chemotherapy. Cancer Res 40: 2209–2212Google Scholar
  73. 73.
    Lykkesfelt AE, Larsen JK, Christensen IJ, Briand P (1984) Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7. Br J Cancer 49: 717–722Google Scholar
  74. 74.
    MacKintosh FR, Evans TL, Sikic BI (1981) Methodologic problems in clonogenic assays of spontaneous human tumours. Cancer Chemother Pharmacol 6: 205–210PubMedGoogle Scholar
  75. 75.
    Madeddu L, Roy F, Leclercq G (1986) A new method for evaluating the inhibitory potency of antiestrogens on breast cancer cell lines. Anticancer Res 6: 11–16PubMedGoogle Scholar
  76. 76.
    Mann BD, Kern DH, Guiliano AE, Burk MW, Campbell MA, Morton DL (1982) Clinical correlations with drug sensitivities in the clonogenic assay: retrospective pilot study. Arch Surg 117: 33–36PubMedGoogle Scholar
  77. 77.
    Masters JRW (1983) An overview of the role of organ culture for human tumour biopsies. In: Dendy PP, Hill BT (ed) Human tumour drug sensitivity testing in vitro. Academic, London, pp 163–177Google Scholar
  78. 78.
    Matsushima Y, Kanzawa F, Hoshi A, Shimizu E, Nomori H, Sasaki Y, Saijo N (1985) Time-schedule dependency of the inhibiting activity of various anticancer drugs in the clonogenic assay. Cancer Chemother Pharmacol 14: 104–107PubMedGoogle Scholar
  79. 79.
    Mattern J, Volm M (1982) Clinical relevance of predictive tests for cancer chemotherapy. Cancer Treat Rev 9: 267–298PubMedGoogle Scholar
  80. 80.
    McGrath CM (1983) Augmentation of response of normal mammary epithelial cells to estradiol by mammary stroma. Cancer Res 43: 1355–1360PubMedGoogle Scholar
  81. 81.
    Miller BE, McInerney D, Jackson D, Miller FR (1986) Metabolic cooperation between mouse mammary tumor subpopulations in three-dimensional collagen gel cultures. Cancer Res 46: 89–93PubMedGoogle Scholar
  82. 82.
    Miller FR, Medina D, Heppner GH (1981) Preferential growth of mammary tumors in intact mammary fat pads. Cancer Res 41: 3863–3867PubMedGoogle Scholar
  83. 83.
    Miller BE, Miller FR, Heppner GH (1984) Assessing tumor drug sensitivity by a new in vitro assay which preserves tumor heterogeneity and subpopulation interactions. J Cell Physiol [Suppl] 3: 105–116Google Scholar
  84. 84.
    Miller BE, Miller FR, Heppner GH (1985) Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures. Cancer Res 45: 4200–4205PubMedGoogle Scholar
  85. 85.
    Moon TE (1980) Quantitative and statistical analysis of the association between in vitro and in vivo studies. In: Salmon SE (ed) Cloning of human tumor stem cells. Liss, New York, pp 209–221Google Scholar
  86. 86.
    Morgan D, Freshney RI, Darling JL, Thomas DGT, Celik F (1983) Assay of anticancer drugs in tissue culture: cell cultures of biopsies from human astrocytoma. Br J Cancer 47: 205–214PubMedGoogle Scholar
  87. 87.
    Myers CE, Young RC, Chabner BA (1976) Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor. Cancer Res 36: 1653–1658PubMedGoogle Scholar
  88. 88.
    Nederman T, Twentyman P (1984) Spheroids for studies of drug effects. In: Acker H, Carlsson J, Durand R, Sutherland R (eds) Spheroids in cancer research. Springer, Berlin Heidelberg New York, pp 84–102 (Recent results cancer research, vol 95)Google Scholar
  89. 89.
    Osborne CK, Boldt DH, Estrada P (1984) Human breast cancer cell cycle synchronization by oestrogens and antioestrogens in culture. Cancer Res 44: 1433–1439PubMedGoogle Scholar
  90. 90.
    Osborne CK, Von Hoff DD, Mullins K (1985) Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay. Breast Cancer Res Treat 6: 229–235PubMedGoogle Scholar
  91. 91.
    Ozols R, Gratzinger K, Myers C, Young RC (1979) Ovarian cancer (OC): intraperitoneal (IP) therapy with adriamycin (ADR). Proc Am Assoc Cancer Res 20: 978Google Scholar
  92. 92.
    Page MJ, Field JK, Everett NP, Green CD (1983) Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7. Cancer Res 43: 1244– 1250PubMedGoogle Scholar
  93. 93.
    Park CH, Bergasgel DE, McCulloch EA (1971) Mouse myeloma tumor stem cells: a primary cell culture assay. J N C I 46: 411–422Google Scholar
  94. 94.
    Poulsen HS, Bichel P, Andersen J (1982) Short-term culture of human breast cancer: in vitro effects of hormones related to patient response. Br J Cancer 46: 67–74PubMedGoogle Scholar
  95. 95.
    Puck TT, Marcus PI (1955) A rapid method of viable cell titration and clone production with Hela cells in tissue culture: the use of X-irradiated cells to supply conditioning factors. Proc Natl Acad Sci USA 41: 432–437PubMedGoogle Scholar
  96. 96.
    Reddel RR, Murphy LC, Sutherland RL (1984) Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen. Cancer Res 44: 2398–2405PubMedGoogle Scholar
  97. 97.
    Richards J, Pasco D, Yang J, Guzman R, Nandi S (1983) Comparison of the growth of normal and neoplastic mouse mammary cells on plastic, on collagen gels and in collagen gels. Exp Cell Res 146: 1–14PubMedGoogle Scholar
  98. 98.
    Roobol C, Sips HCM, Theunissen J, Atassi G, Bernheim JL (1984) In vitro assessment of cytotoxic agents in murine cancers: comparison between antiproliferative and antimetabolic assays. J N C I 72: 661–666Google Scholar
  99. 99.
    Rose C, Mouridsen HT (1984) Combined cytotoxic and endocrine therapy in breast cancer. In: Bresciani F, King RJB, Lippman ME, Namer M, Raynaud J-P (eds) Progress in cancer research and therapy vol 31. Raven, New York, pp 269–286Google Scholar
  100. 100.
    Rosenblum ML, Dougherty DV, Reese C, Wilson CB (1981) Potentials and possible pitfalls of human stem cell analysis. Cancer Chemother Pharmacol 6: 227–235PubMedGoogle Scholar
  101. 101.
    Salmon SE, Alberts DS, Durie BGM, Meyskens FL, Jones SE, Soehnlen B, Chen WS, Moon T (1980) Clinical correlations of drug sensitivity in the human tumor stem cell assay. In: Mathe G, Muggia FM (eds) Cancer chemo- and immunopharmacology I. Springer, Berlin Heidelberg New York, pp. 300–305 (Recent results in cancer research, vol 74)Google Scholar
  102. 102.
    Salmon SE, Hamburger AW, Soehnlen B, Durie BG, Alberts DS, Moon TE (1978) Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs. N Engl J Med 298: 1321–1327PubMedGoogle Scholar
  103. 103.
    Salmon SE, Trent JM (eds) (1984) Human tumor cloning. Grune and Stratton, OrlandoGoogle Scholar
  104. 104.
    Sandbach J, Von Hoff DD, Clark G, Cruz AB, O’ Brien M (1982) Direct cloning of human breast cancer in soft agar culture. Cancer 50: 1315–1321PubMedGoogle Scholar
  105. 105.
    Sanfilippo O, Daidone MG, Costa A, Canetta R, Silvestrini R (1981) Estimation of differential in vitro sensitivity of non-Hodgkin lymphomas to anticancer drugs. Eur J Cancer 17: 217–226PubMedGoogle Scholar
  106. 106.
    Sasaki T, Yamamoto M, Kuwahara K (1984) Lethal effect of bleomycin and peplo- mycin on Hela cells in multicell tumor spheroids. Cancer Res 44: 1374–1379PubMedGoogle Scholar
  107. 107.
    Sato G (1975) The role of serum in culture. In: Litwak G (ed) Biochemical action of hormones, vol 3. Academic, New York, pp 391–396Google Scholar
  108. 108.
    Sauter C, Cogoli M, Arrenbrecht S (1986) Interactions of cytotoxic and other drugs: rapid cell culture assay. Oncology 43: 46–49PubMedGoogle Scholar
  109. 109.
    Selby P, Buick RN, Tannock I (1983) A critical appraisal of the “Human tumour stemcell assay”. N. Engl J Med 308: 129–134Google Scholar
  110. 110.
    Sikic BI, Taber RL (1981) Human tumor clonogenic assays. Cancer Chemother Pharmacol 6: 201–203PubMedGoogle Scholar
  111. 111.
    Silvestrini R, Daidone MG, Costa A, Sanfilippo O (1985) Cell kinetics and in vitro chemosensitivity as a tool for improved management of patients. Eur J Cancer Clin Oncol 21: 371–378PubMedGoogle Scholar
  112. 112.
    Smith HS, Lan S, Ceriani R, Hackett AJ, Stampfer MR (1981) Clonal proliferation of cultured nonmalignant and malignant human breast epithelia. Cancer Res 41: 4637– 4643PubMedGoogle Scholar
  113. 113.
    Smith HS, Lippman ME, Hiller AJ, Stampfer MR, Hackett AJ (1985) Response to doxorubicin of cultured normal and cancerous human mammary epithelial cells. J N C I 74: 341–347Google Scholar
  114. 114.
    Sondak VK, Bertelsen CA, Tanigawa N, Hildebrand-Zanki SU, Morton DL, Korn EL, Kern DH (1984) Clinical correlations with chemosensitivities measured in a rapid thymidine incorporation assay. Cancer Res 44: 1725–1728PubMedGoogle Scholar
  115. 115.
    Sondak VK, Giuliano AE, Kern DH (1984) Outcome of “non-malignant” specimens submitted for soft-agar clonogenic assay. In: Salmon SE, Trent JM (eds) Human tumor cloning. Grune and Stratton, Orlando, pp 327–341Google Scholar
  116. 116.
    Soule HD, McGrath CM (1986) A simplified method for passage and long-term growth of human mammary epithelial cells. In Vitro Cell Dev Biol 22: 6–12PubMedGoogle Scholar
  117. 117.
    Speyer JL, Collins JM, Dedrick RL, Brennan MF, Londer H, DeVita VT Jr, Myers CE (1979) Phase I and pharmacological studies of intraperitoneal (IP) 5-fluorouracil (5- FU). Proc Am Soc Clin Oncol 20: C-251Google Scholar
  118. 118.
    Sutherland RM, Durand RE (1976) Radiation response of multicell spheroids: an in vitro tumour model. Curr Top Radiat Res 11: 87–139Google Scholar
  119. 119.
    Tanigawa N, Kern DH, Hikasa Y, Morton DL (1982) Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture. Cancer Res 42: 2159–2164PubMedGoogle Scholar
  120. 120.
    Taylor-Papadimitriou J, Sheares M, Stoker MGP (1977) Growth requirements of human mammary epithelial cells in culture. Int J Cancer 20: 903–908PubMedGoogle Scholar
  121. 121.
    Thomas DGT, Darling JL, Paul EA, Mott TJ, Godlee JN, Tobias JS, Capra LG, Collins CD, Mooney C, Bozek T, Finn GP, Arigbabu SO, Bullard DE, Shannon N, Freshney RI (1985) Assay of anti-cancer drugs in tissue culture: relationship of relapse free interval (RFI) and in vitro chemosensitivity in patients with malignant cerebral glioma. Br J Cancer 51: 525–532PubMedGoogle Scholar
  122. 122.
    Tubiana M, Pejovic MH, Chavaudra N, Contesso G, Malaise EP (1984) The long-term prognostic significance of the thymidine labelling index of breast cancer. Int J Cancer 33: 441–445PubMedGoogle Scholar
  123. 123.
    Twentyman PR (1985) Predictive chemosensitivity testing. Br J Cancer 51: 295–299PubMedGoogle Scholar
  124. 124.
    Twentyman PR, Fox NE, Wright KA, Workman P, Broadhurst MJ, Martin JA, Bleehen NM (1986) The in vitro effects and cross-resistance patterns of some novel anthracyclines. Br J Cancer 53: 585–594PubMedGoogle Scholar
  125. 125.
    Twentyman PR, Walls GA, Wright KA (1984) The response of tumour cells to radiation and cytotoxic drugs—a comparison of clonogenic and isotope uptake assays. Br J Cancer 50: 625–631PubMedGoogle Scholar
  126. 126.
    Van den Berg HW, Clarke R, Murphy RF (1981) Failure of 5-fluorouracil and methotrexate to destroy the reproductive integrity of a human breast cancer cell line (MCF-7) growing in vitro. Eur J Cancer Clin Oncol 17: 1275–1281PubMedGoogle Scholar
  127. 127.
    Volm M, Wayss K, Kaufmann M, Mattern J (1979) Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy. Eur J Cancer 15: 983–993PubMedGoogle Scholar
  128. 128.
    Von Hoff DD, Clark GM, Forseth BJ, Cowan JD (1986) Simultaneous in vitro drug sensitivity testing on tumours from different sites in the same patient. Cancer 58: 1007– 1013Google Scholar
  129. 129.
    Von Hoff DD, Clark GM, Weiss GR, Marshall MH, Buchok JB, Knight III WA, LeMaistre CF (1986) Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimens. J Clin Oncol 4: 1827–1834Google Scholar
  130. 130.
    Von Hoff DD, Cowan J, Harris G, Reisdorf G (1981) Human tumor cloning: feasibility and clinical correlations. Cancer Chemother Pharmacol 6: 265–271Google Scholar
  131. 131.
    Von Hoff DD, Forseth B, Gonzales L (1986) Culture and sensitivity of tumors. Tex Med 82: 32–35Google Scholar
  132. 132.
    Von Hoff DD, Forseth B, Warfel LE (1985) Use of a radiometric system to screen for antineoplastic agents: correlation with a human tumor cloning system. Cancer Res 45: 4032–4038Google Scholar
  133. 133.
    Weichselbaum RR, Nove J, Heilman S, Piro AJ, Little JB (1979) Combination hormonal, chemotherapy and radiotherapy in vitro: implications for therapy in vivo. Int J Radiat Oncol Biol Phys 5: 1657–1661PubMedGoogle Scholar
  134. 134.
    Weisenthal LM, Marsden JA, Dill PL, Macaluso CK (1983) A novel dye exclusion method for testing in vitro chemosensitivity of human tumors. Cancer Res 43: 749–757PubMedGoogle Scholar
  135. 135.
    Wei-Zen W, Massey RJ, Heppner GH (1985) A 3-dimensional tumour growth inhibition assay for testing monoclonal antibody cytotoxicity. Cancer Immunol Immunother 20: 137–144Google Scholar
  136. 136.
    Wheeler TK, Dendy PP, Dawson A (1974) Assessment of an in vitro screening test of cytotoxic agents in the treatment of advanced malignant disease. Oncology 30: 362–376PubMedGoogle Scholar
  137. 137.
    Wilde CJ, Hasan HR, Mayer RJ (1984) Comparison of collagen gels and mammary extracellular matrix as substrata for study of terminal differentiation in rabbit mammary epithelial cells. Exp Cell Res 151: 519–532PubMedGoogle Scholar
  138. 138.
    Wilson AP, Ford CHJ, Newman CE, Howell A (1984) A comparison of three assays used for the in vitro chemosensitivity testing of human tumours. Br J Cancer 49: 57–63PubMedGoogle Scholar
  139. 139.
    Wilson AP, Neal FE (1981) In vitro sensitivity of human ovarin tumours to chemotherapeutic agents. Br J Cancer 44: 189–200PubMedGoogle Scholar
  140. 140.
    Wright JC, Cobb JP, Gumport SL, Golomb FM, Safodi D (1957) Investigation of the relation between clinical and tissue culture response to chemotherapeutic agents of human cancer. New Engl J Med 257: 1207–1211PubMedGoogle Scholar
  141. 141.
    Yang J, Elias JJ, Petrakis NL, Wellings SR, Nandi S (1982) Effects of hormones and growth factors on human mammary epithelial cells in collagen gel culture. Cancer Res 41: 1021–1027Google Scholar
  142. 142.
    Yang J, Larson L, Flynn D, Elias J, Nandi S (1982) Serum-free primary culture of human normal mammary epithelial cells in collagen gel matrix. Cell Biol Int Rep 6:965– 975Google Scholar
  143. 143.
    Yang N, Kube D, Park C, Furmanski P (1981) Growth of human mammary epithelial cells on collagen gel surfaces. Cancer Res 41: 4093–4100PubMedGoogle Scholar
  144. 144.
    Yuhas JM, Li AP, Martinez AO, Ladman AJ (1977) A simplified method for production and growth of multicellular tumour spheroids. Cancer Res 37: 3639–3643PubMedGoogle Scholar
  145. 145.
    Zirvi KA, Hill GJ, Hill HZ (1986) Comparative studies of chemotherapy of human tumor cells in vitro by tritiated thymidine uptake inhibition and soft agar clonogenic assay. J Surg Oncol 31: 123–126PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1989

Authors and Affiliations

  • J. T. Emerman
    • 1
  1. 1.Department of AnatomyUniversity of British ColumbiaVancouverCanada

Personalised recommendations